Mealey's (March 19, 2021, 2:07 PM EDT) -- BROOKLYN, N.Y. — A federal judge in New York on March 16 denied a motion to alter or amend his judgment dismissing federal securities law claims filed by an investor in a securities class action against a generic drug maker and several of its current and former executive officers for failure to sufficiently plead scienter, ruling that the investor’s basis for his motion does not constitute an intervening change of law in the action....